| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 144 |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
Reports revenue of $19.3 million for the third quarter of 2026, company reiterates full-year revenue guidance |
| 10 Nov 2026 |
Form 4: De Vre Raymond, Director
Sold 1,088 shares ($1.21K) |
| 10 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
[***] Certain marked information has been omitted from this exhibit because it is both not material and is the type that the Registrant treats as private or confidential. |
| 06 Nov 2026 | SCHEDULE 13G/A |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 14 Oct 2026 |
Form 4: Erbez Georgia, See Remarks
Sold 6,335 shares ($8.62K) |
| 14 Oct 2026 |
Form 4: Moore Alison, Director
Sold 6,335 shares ($8.62K) |
| 13 Oct 2026 | 144 |
| 13 Oct 2026 | 144 |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
Reports revenue of $14.9 million for the second quarter of 2026, company reiterates full-year financial guidance |
| 29 Jul 2026 | SCHEDULE 13G |
| 27 Jul 2026 |
8-K: Other Events
Introductory. Codexis, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 16,666,667 shares of its common stock, par value $0.0001... |
| 24 Jul 2026 | 424B5 |
| 23 Jul 2026 | 424B5 |
| 23 Jul 2026 |
8-K: Results of Operations and Financial Condition; Other Events
On July 23, 2026, Codexis, Inc. (the “Company”) disclosed that it expects to report total revenue for the three months ended June 30, 2026 to be at least $14.8 million, and cash, cash equivalents and short-term investments as of June 30,... |
| 20 Jul 2026 | SCHEDULE 13G/A |
Loading...